Research and Markets: United States In Vitro Diagnostics Market Outlook to 2016

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5847e2/united_states_in_v) has announced the addition of GlobalData's new report "United States In Vitro Diagnostics Market Outlook to 2016" to their offering.

“United States In Vitro Diagnostics Market Outlook to 2016”

Our new report, US In Vitro Diagnostics Market Outlook to 2016 provides key market data on the US In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope:

• Market size and company share data for In Vitro Diagnostics (IVD) market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the US In Vitro Diagnostics (IVD) market.
• Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy:

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the US In Vitro Diagnostics (IVD) competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Key Topics Covered:

1 Table of Contents 2 Introduction

3 In Vitro Diagnostics In United States

4 Clinical Chemistry In United States

5 Genetic Testing In United States

6 Haematology In United States

7 Histology And Cytology In United States

8 Immuno Chemistry In United States

9 Infectious Immunology In United States

10 Microbiology Culture In United States

11 Overview of Key Companies in United States In Vitro Diagnostics Market

12 In Vitro Diagnostics Market Pipeline Products

13 Financial Deals Landscape

14 Recent Developments

15 Appendix

55 Companies Mentioned in this Report, Some Include:

• Siemens Healthcare
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Ortho-Clinical Diagnostics Inc.
• Genzyme Corporation
• Inverness Medical Innovations, Inc.
• Baxter International Inc.
• Assay Designs, Inc.
• BioTime, Inc.
• AdvanDx, Inc.
• Biocare Medical LLC
• Biocell Laboratories, Inc.
• Protein Discovery, Inc.
• Binax, Inc.
• SYNTRON Bioresearch, Inc.
• Bio/Data Corporation
• Cartagen Molecular Systems, Inc.
• Maxwell Sensors Inc.
• Biomedical Science Consulting Company, Inc.
• BellBrook Labs
• Monogen, Inc.
• INOVA Diagnostics, Inc.
• Haematologic Technologies, Inc.
• EraGen Biosciences, Inc.

For more information visit http://www.researchandmarkets.com/research/5847e2/united_states_in_v